Total liabilities · 2019–2025

Keros Therapeutics total liabilities

$34.9M−21.3% · FY2025

Keros Therapeutics (KROS) reported $34.9M in total liabilities for fiscal 2025, −21.3% year on year.

$10.5M2019$7.7M2020$12.1M2021$29.4M2022$37.8M2023$44.3M2024$34.9M2025
Keros Therapeutics — Total liabilities, 2019–2025
Fiscal yearTotal liabilitiesChangeFiling
FY20252025-12-31$34.9M−21.3%Open →
FY20242024-12-31$44.3M+17.2%Open →
FY20232023-12-31$37.8M+28.8%Open →
FY20222022-12-31$29.4M+143.1%Open →
FY20212021-12-31$12.1M+56.4%Open →
FY20202020-12-31$7.7M−26.2%Open →
FY20192019-12-31$10.5M—Open →

Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +22.2%

Total liabilities at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Keros Therapeutics total liabilities |url=https://companiesranked.com/en/company/keros-therapeutics/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Keros Therapeutics total liabilities. CompaniesRanked. https://companiesranked.com/en/company/keros-therapeutics/total-liabilities

BibTeX

@misc{companiesranked-en-company-keros-therapeutics-total-liabilities-2026,
  author       = {{CompaniesRanked}},
  title        = {{Keros Therapeutics total liabilities}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/keros-therapeutics/total-liabilities}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001664710-26-000049 · August 3, 2026

{{cite web |title=Keros Therapeutics total liabilities — 10-Q (0001664710-26-000049) |url=https://www.sec.gov/Archives/edgar/data/1664710/000166471026000049/kros-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Keros Therapeutics overview